Related Experiment Videos
[How do antipsychotics exert their effects on dopamine receptor subtypes?].
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica
|April 15, 1999
Summary
Novel antipsychotic drugs are being developed to improve schizophrenia treatment and reduce side effects. Research on dopamine receptor subtypes, like D2, offers new insights into schizophrenia
Area of Science:
- Neuroscience
- Pharmacology
Context:
- Schizophrenia treatment seeks novel antipsychotics with better efficacy and fewer side effects.
- The dopaminergic hypothesis of schizophrenia is being re-evaluated based on novel antipsychotic drug effects.
Purpose:
- To provide an overview of the effects of antipsychotics on dopamine receptor subtypes.
- To discuss the role of dopamine D2 receptors in the efficacy and side effects of antipsychotic medications.
Summary:
- Aripiprazole, a novel antipsychotic, exhibits high-affinity antagonism at dopamine D2 receptors.
- Chronic administration of aripiprazole in rats shows differential effects on D2 receptors in the striatum and pituitary compared to haloperidol.
- D2 receptor occupancy in the striatum is implicated in the extrapyramidal side effects of typical antipsychotics.
Impact:
- Findings contribute to understanding schizophrenia pathophysiology and developing safer, more effective treatments.
- Highlights the importance of dopamine receptor subtype selectivity in antipsychotic drug design.